FDA approves Eli Lilly’s blood cancer drug – Reuters.com
Jan 27 (Reuters) – Eli Lilly and Co said on Friday the U.S. health regulator approved its drug for the treatment of a rare form of blood cancer.
The Food and Drug Administration gave accelerated app… [read more]